Key Benefits
Glimfirst-MV2 Tablet 10’s contains Glimepiride, Metformin and Voglibose. Glimepiride, which is a ‘sulfonylurea’, acts by increasing the amount of insulin released by the pancreas. Metformin, which is a ‘biguanide’, acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body’s response to insulin. Voglibose, which is an ‘alpha-glucosidase inhibitor’ prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. Glimfirst-MV2 Tablet 10’s prevents the blood glucose levels from rising to very high levels thus keeping your diabetes under control. Glimfirst-MV2 Tablet 10’s also helps to prevent serious complications of diabetes such as kidney damage (Diabetic Nephropathy), blindness (Diabetic Retinopathy), loss of sensation in your hands and feet (Diabetic Neuropathy), Glimfirst-MV2 Tablet 10’s also helps to reduce your chance of having a heart attack or stroke. Being a combination of three drugs, Glimfirst-MV2 Tablet 10’s reduces the need to take multiple pills and hence makes it easier to remember to take the drugs.
Directions for Use
Side Effects
- Hypoglycaemia (low blood glucose level)
- Taste change
- Nausea
- Diarrhoea
- Stomach pain
- Flatulence
- Headache
- Upper respiratory symptoms